ISI Names Adam Sherlock as its Director of Business Development
20 year business development, marketing and general management veteran from the Life Sciences sector to boost ISI’s international management team and lead its aggressive market growth
Frankfurt, Germany (June 4, 2007) – June 4th, 2007 - Image Solutions Inc. (ISI), the regulatory submissions software and services company, today announced that it has fortified its marketing and business development experience pool with the appointment of UK-based Adam Sherlock to its executive team as director of business development.
Adam comes to ISI with an impressive career that spans some 20 years in the IT industry specifically providing solutions to life sciences companies. As chief operating officer of IQ Consultancy, a provider of change management services to the pharmaceutical industry, Adam’s extensive business management experience was instrumental in securing the company’s successful acquisition by a major Swedish IT consultancy firm. Prior to IQ Consultancy, Adam was founder and managing director of the Synapse Partnership, a company specialising in regulatory software for the life sciences market. Under Adam’s ten year stewardship, the Synapse Partnership has developed into a highly profitable, reputable and specialist consultancy. Adam also served as director of business development at medical communications agency, Gardner Caldwell where during his five year tenure he grew revenues from $5M to $20M.
Gilbert Kampfner is managing director of ISI Europe and comments, "With Adam on board directing business development, we are in a great position to capitalise on our strong growth in Europe and internationally. He has significant experience in sales, international marketing and operations at technology companies and this expertise will be invaluable as we expand our market share with new technologies and services.” Gilbert continues, “This is a very exciting time for ISI. We have just unveiled our end-to-end submission management solution - truly a technology milestone in regulatory submissions as it now gives life sciences organisations of all sizes one flexible, integrated and comprehensive platform from which to manage, develop, review and publish eCTD, electronic and paper submissions. With Adam’s extensive regulatory knowledge we further extend our ability to deliver on this unique services and technology proposition.”
Speaking of his appointment Adam commented, “I am delighted to be part of this global success story. ISI has a much deserved reputation for delivering world-class technology to life sciences companies and it can boast an outstanding track-record and highly referenceable customer base.” Adam continues, “Software however is only one part of the picture; it is the company’s relentless focus on a world-class services capability that separates ISI from the fold and I am delighted to have an opportunity to add my experience to that knowledge-pool and grow market share and identify new delivery channels .”
Adam was awarded his honours degree in Applied Microbiology from Liverpool University and his post-graduate diploma in Marketing from the Chartered Institute of Marketing.